Safety and Efficacy of a Bausch & Lomb Multipurpose Solution When Compared to Ciba Vision Aquify Multipurpose Solution
- Conditions
- Contact Lens Solutions
- Interventions
- Device: Bausch & Lomb Multipurpose Solution - No Rub CareDevice: Bausch & Lomb Multipurpose Solution - Rub CareDevice: Ciba Vision Aquify Multipurpose Solution
- Registration Number
- NCT00636363
- Lead Sponsor
- Bausch & Lomb Incorporated
- Brief Summary
To the safety and efficacy of a Bausch \& Lomb Multipurpose Solution when compared to Ciba vision Aquify Multipurpose solution
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 541
- subject is a habitual wearer of a silicone hydrogel or group IV contact lens
- VA correctable to 0.3 LogMar or better (driving vision)
- Clear central cornea
- Subject uses a lens care system on a regular basis
- Systemic disease affecting ocular health
- Using systemic or topical medications
- wear monovision, multifocal or toric contact lenses
- Any grade 2 or greater slit lamp findings
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Multipurpose Solution - No Rub Care Bausch & Lomb Multipurpose Solution - No Rub Care Bausch \& Lomb Multipurpose Solution for use with contact lens care Multipurpose Solution - Rub Care Bausch & Lomb Multipurpose Solution - Rub Care Bausch \& Lomb Multipurpose Solution for use with contact lens care Ciba Vision Aquify Multipurpose Solution Ciba Vision Aquify Multipurpose Solution Ciba Vision Aquify Multipurpose Solution for use with contact lens care
- Primary Outcome Measures
Name Time Method Slit-lamp Findings > Grade 2 Over 4 visits for 3 month period eyes with any slit lamp findings greater than Grade 2 at any visit. Slit lamp findings for each eye will be graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). Epithelial edema, epithelial microcysts, corneal staining, limbal injection, bulbar injection, superior tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates will be assessed.
Subjective Responses to Comfort Related Symptoms/Complaints Over 4 visits for the 3 month period Subject symptoms/complaints will be assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.
Contact Lens Deposits At each visit for 3 months Lens deposits assessed at each follow-up visit. Degree of deposits assessed as none, light, medium, or heavy.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Place Eye Care
🇺🇸LeRoy, New York, United States